Stopping Cancer Early – The Best Possible Investment


Our Newest Faculty Member Arrives from Harvard: Dr. Utkan Demirci – A Microfluidic Technology Platform

March 6, 2014

To implement new discoveries in the clinic, we are committed to developing novel micro- and nanoscale bioengineering and biomedical microfluidic technology platforms to enable clinical diagnostics and point-of-care tests. To achieve this goal, we have recently recruited Dr. Utkan Demirci from Harvard Medical School to lead our technology development efforts. Dr. Demirci’s previous efforts have yielded a point-of-care microchip technology to detect ovarian cancer biomarkers (e.g., HE4) using a 10-minute microchip assay and a cell phone as the detector.

Screen Shot 2014-03-18 at 10.36.05 AM

Dr. Demirci will continue to innovate around point-of-care diagnostics, microfluidics assays and the development of technology platforms at the convergence of engineering, biology and materials science. Dr. Demirci brings his 15-person lab from Harvard this spring.

Further details of his research can be found here.  The movie below, from BAMM Labs (Bio Acoustic Mems in Medicine) gives the general idea of his point-of-care diagnostic technology although it’s for a different medical application.